Kolexia
Charabiani-Bagheri Haleh
Pharmacien
Hôpital Purpan
Toulouse, France
174 Activités
18 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Effets secondaires indésirables des médicaments COVID-19 Hémorragie Arthrite Diabète Polyarthrite rhumatoïde Hypertension artérielle Perte d'audition Toxidermies

Industries

THERAMEX FRANCE
2 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Bariatric surgery and drugs: Review of the literature and Adverse Drug Reactions analysis in French National Pharmacovigilance Database.
Therapie   24 février 2024
Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment.
Vaccines   11 février 2024
Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions.
Therapie   12 janvier 2024
Breathing in the future: prenatal exposure to air pollution and infants' health outcomes in the USA.
Public health   06 novembre 2023
Patient's reporting of adverse drug reactions: Which added value in 2023?
Therapie   31 octobre 2023
Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study.
Expert opinion on drug safety   21 août 2023
Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database.
JMIR public health and surveillance   14 juillet 2023
Sudden sensorial hearing loss following mRNA COVID-19 vaccines and safety signal generation: National cross-sectional audiogram-based study
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Mianserin-induced sexual behaviour disorders: A case series
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Vascular Endothelial Growth Factor inhibitors-induced Systemic Adverse Drug Reactions: Review of the French Pharmacovigilance Data Base
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023